Armata Pharmaceuticals Inc Sustainability Reports
Armata Pharmaceuticals Inc. focuses on developing bacteriophage-based therapies to treat antibiotic-resistant bacterial infections.
Sector: Health Care
Country: United States
Exchange: NYSE American
ISIN: US04216R1023
4 reports from 2019 to 2024
Company Profile
Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc. focuses on developing bacteriophage-based therapies to treat antibiotic-resistant bacterial infections.
Reports